市場調查報告書

無鉛心臟心律調節器的全球市場:成長,趨勢,及預測

Leadless Cardiac Pacemaker Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 391336
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
無鉛心臟心律調節器的全球市場:成長,趨勢,及預測 Leadless Cardiac Pacemaker Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年04月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球無鉛心臟心律調節器市場的相關調查,市場機會和趨勢,成長及阻礙因素,各類型、產品、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的假設
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各類型
    • 多零組件
    • 單一零組件
  • 各產品
    • Micra經導管起搏統
    • Nanostim無導線心律調節器
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 49765

Market Overview

Leadless cardiac pacemakers are medical devices that are used for the treatment of patients who are suffering from heart-related disorders, like arrhythmias. These pacemakers are expected to transform the cardiac rhythm management (CRM) market in the coming years with their potential to reduce complications and shorter recovery times.

  • The major factors driving the leadless pacemakers (LCP) market are the aging population, increasing incidences of heart diseases, and technological advancements.
  • In addition, other important factors, like avoidance of lead-related and pocket-related complications, such as infection and disfigurement, MRI compatibility, and no postoperative mobility restrictions add advantages to the leadless pacemakers in the market. They are retrievable for a longer time interval post-implantation, which is expected to create substantial opportunities in the market.

Scope of the Report

A pacemaker is a small medical device that uses electrical impulses, synthetically produced by its electrodes, to regulate the heartbeat at a normal rate. It is usually recommended for certain heart conditions, like arrhythmia, tachycardia, and heart block. A leadless cardiac pacemaker is designed to achieve the same pacing results, but the process for implanting is different from the standard pacemakers. For a standard pacemaker, a surgical pocket is created to implant the pacemaker, and leads are then attached to the pacemaker. Leads are thin, soft, and insulated wires that carry the electrical impulse from the pacemaker to the heart and regulate the pace of the heart. However, a leadless pacemaker does not require any surgical pocket or leads.

Key Market Trends

Nanostim and Micra are Expected to Remain Major Products in the Leadless Cardiac Pacemaker Market During the Forecast Period

Nanostim and Micra TPS are two key innovations. Both the devices are single-chamber pacemakers placed directly into the heart with a steerable catheter through the femoral vein. The procedure times with the Micra and Nanostim devices are shorter (lasting from 30 to 45 minutes), than those with the traditional pacemakers. They are self-contained intracardiac devices that include pacemaker electronics, battery, and leads. Both devices can be implanted in the same minimally invasive setting as some traditional pacemakers. Leadless pacemakers are expected to expand their market share rapidly, by displacing traditional cardiac pacemakers, during the forecast period. However, Abbott recalled its leadless pacemakers from the market following reports of sudden battery depletion. Moreover, in November 2017, Abbott issued a halt on implantations of Nanostim pacemakers, citing docking button issues, which continued as of March 2018.

The United States is Expected to Dominate the Leadless Cardiac Pacemaker Market

The United States is expected to dominate the leadless cardiac pacemaker market, due to the high prevalence of cardiovascular diseases, high adoption rates of leadless pacemakers, and availability of reimbursements.

Competitive Landscape

As of March 2019, only two leadless pacemaker systems were commercially available in the market, having slightly different sizes and implantation requirements, which are Nanostim (Abbott Laboratories) and Micra (Medtronic PLC). However, Boston Scientific, one of the leading pacemaker manufacturers, has been developing its own leadless pacemaker system.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Avoidance of Lead-related Complications
    • 4.2.3 MRI Compatibility
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement Issues
    • 4.3.2 Limited Use of Single-chamber Right Ventricular Pacing
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Multi-component Leadless Pacemaker
    • 5.1.2 Single-component Leadless Pacemaker
  • 5.2 By Product
    • 5.2.1 Micra Transcatheter Pacing System
    • 5.2.2 Nanostim Leadless Pacemaker
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Medtronic PLC
    • 6.1.3 Boston Scientific Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS